About Us

Fellows Research Alliance is a clinical trials management and consulting group dedicated to research and development in an effort to bring new and safer products to patients. Our staff consists of highly trained physicians and clinical research professionals with over 50 years of clinical research experience. Fellows Research Alliance is currently serving the Georgia and South Carolina Coastal Empire. Our clinical research team has an extensive and diverse background that is beneficial to the patient, the medical community and the pharmaceutical industry.

With a diverse team of physician investigators, Fellows Research Alliance has the capability to conduct many trials within different indications. Our physician investigators have clinical experience in internal medicine, women’s health, pediatrics, GI health, respiratory, infectious diseases, endocrinology, as well as many others.

Fellows Research Alliance is proud of the close working relationship with its physicians, patients and pharmaceutical sponsors, and the integrity of our staff. Since March, 2008, all of our principal investigators are Certified Physician Investigators through the ACRP/APPI. We are committed to providing outstanding patient care within the context of research and quality research data.

In October, 2012, Fellows Research Alliance has partnered with Southcoast Medical Group to conduct clinical trials.  This partnership will allow both companies to conduct a more diverse range of clinical trials in the Coastal Empire area.

Meet the Staff

Dwan Fellows

Dwan Fellows

President/CEO

Monique Ooley

Monique Ooley

Clinical Director

Debra Walland, MD, FACOG, CPI

Debra Walland, MD, FACOG, CPI

Medical Director

Chris Fellows

Chris Fellows

CFO

Facebook Posts

If you have been told that you should be on medication for high cholesterol but you just can't take the "statin" medications, we have a study for an investigational cholesterol medication being developed to avoid the usual side effects. Call us at (912) 355-4447 for more info. ... See MoreSee Less

View on Facebook

It is still not too late to get a flu shot. In the SE part of the country 8 out of 8 jurisdictions are reporting widespread or regional activity. Sadly, there have been 12 pediatric deaths. ... See MoreSee Less

View on Facebook

Leading the News
Widespread Shortage Of Ob-Gyns Found Throughout The US.
Scientific American (2/15, Maron) reports that there appears to be a widespread shortage of ob-gyns in rural America. For example, in 1980, “45 of Alabama’s 54 rural counties had hospitals providing obstetrical services. Today only 16 of them offer such care, and doctors say that means many women need to drive an hour or more to deliver their babies or even get basic prenatal care from an ob-gyn.” The article adds, “such extreme access problems lead to difficult decisions” on whether or not to get care. The issue with disappearing maternal care is common nationwide. Only “about 6 percent of the nation’s ob-gyns work in rural areas, according to the latest survey numbers from the American Congress of Obstetricians and Gynecologists (ACOG).”
... See MoreSee Less

View on Facebook

Medscape (1/30, Nelson) reports that “exercise does not appear to have any effect on the development of lymphedema in breast cancer patients.” Investigators found that lymphedema rates were nearly the “same for women randomly allocated to receive education only and for women allocated to receive education plus personalized exercise instruction from a physical therapist.” The research was presented at the Cancer Survivorship Symposium Advancing Care and Research. ... See MoreSee Less

View on Facebook

Heavy Periods / Uterine Fibroids
We are currently recruiting participants for this important study is designed to evaluate a new investigational medication for the treatment of heavy periods in women with suspected or known uterine fibroids to see if it decreases heavy periods and reduces the size of uterine fibroids. In order to qualify to participate in this trial you must be:
•Females between the ages of 18-50
•Having monthly periods that are heavy bleeding

Participants will receive a study-related medical examination with laboratory services similar to an annual exam at your GYN (Pap smear, ultrasound, etc) and all study medication at no cost. This clinical trial is being offered at our Savannah, GA office only. Compensation for time and travel will be provided.
... See MoreSee Less

View on Facebook

fellowsresearch.com updated their cover photo. ... See MoreSee Less

View on Facebook

Use Of Mammography Increased Among Older Americans Under ACA, Study Indicates.
On its website, CNN (1/9, Scutti) reports that the Affordable Care Act eliminated many out-of-pocket costs for preventive healthcare services such as mammography and colonoscopy, tests used to detect cancer. According to a new study published in Cancer, the use of mammography increased among older Americans thanks to the ACA, yet no similar gains in the use of colonoscopy were found. Dr. Gregory Cooper, lead author of the study and program director of gastroenterology at University Hospitals Cleveland Medical Center and the Case Comprehensive Cancer Center, explained that the study was undertaken because researchers “wanted to see, as a natural experiment, what happens when you change the financial burden on preventive services.”
... See MoreSee Less

View on Facebook

Women Face Nearly 20% Higher Costs To Cover Medical Bills In Retirement, Report Suggests.
The Wall Street Journal (12/7, Tergesen, Subscription Publication) reports a survey released Wednesday by HealthView Services found that women face nearly 20% higher costs to cover medical bills in retirement. The Journal says longevity is a key factor, since women, on average, live about two years longer than men.
... See MoreSee Less

View on Facebook

Study Indicates Weight Gained During Holidays Takes Five Months To Lose--
The New York Times (10/3, Chokshi, Subscription Publication) reports a study by Professor Brian Wansink of Cornell University’s business school, along with Elina Helander of Tampere University of Technology in Finland and Angela Chieh of Withings, indicates weight gained during the holiday season tends to take “takes about five months to come off,” Wansink said.
In the US, “weights peaked around the New Year” and reached their lowest at the beginning of October – fluctuating “by as much as 0.7 percent over the course of the year, the study found.”
... See MoreSee Less

View on Facebook

Amgen Inc said on Tuesday its potent new cholesterol fighter, Repatha( evolocumab), met the primary and secondary goals of a study designed to show it can decrease plaque buildup in heart arteries of patients already taking widely used statin drugs, such as Lipitor.
Repatha belongs to an expensive new class of injectable drugs that dramatically lower levels of "bad" LDL cholesterol. The new medicines have a list price of more than $14,000 a year. Regeneron Pharmaceuticals and Sanofi sell a rival drug called Praluent. They are far more expensive than statins, which are almost all now available in cheap generic versions.
Unfortunately, health insurers and other companies that negotiate prescription drug usage have been slow to cover the new medicines without evidence that they actually reduce heart attacks and deaths as statins do. Data from large studies expect to show that is expected next year.
"One year after the FDA approved Repatha, nearly two-thirds of patients prescribed Repatha are still being denied access," Amgen research chief Sean Harper said in a statement.
Atherosclerosis is the major underlying cause of cardiovascular disease, which remains the leading cause of death worldwide," Harper said.
Thank you to our volunteers who participated in the completed studies, and to those who are continuing in the long-term trial. This drug would not be available without you.
... See MoreSee Less

View on Facebook
Share on FacebookTweet about this on TwitterShare on LinkedInPin on PinterestShare on Google+